MiR-492 impairs the angiogenic potential of endothelial cells
Article first published online: 26 JUN 2013
© 2013 The Authors. Journal of Cellular and Molecular Medicine Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Journal of Cellular and Molecular Medicine
Volume 17, Issue 8, pages 1006–1015, August 2013
How to Cite
Patella, F., Leucci, E., Evangelista, M., Parker, B., Wen, J., Mercatanti, A., Rizzo, M., Chiavacci, E., Lund, A. H. and Rainaldi, G. (2013), MiR-492 impairs the angiogenic potential of endothelial cells. Journal of Cellular and Molecular Medicine, 17: 1006–1015. doi: 10.1111/jcmm.12085
- Issue published online: 29 AUG 2013
- Article first published online: 26 JUN 2013
- Manuscript Accepted: 13 MAY 2013
- Manuscript Received: 5 DEC 2012
- RSTL-CNR. Grant Number: 783
- EMBO fellowship
Table S1. microRNAs differentially expressed (high glucose versus normal glucose).
Table S2. p- value of miR-492 pull-out genes.
Table S3. Binding sites proposed by Miranda between miR-492 and pull-out targets.
Figure S1. Transfection efficiency of HUVEC.
Figure S2. Expression of miR-492 in human tissues.
Figure S3. Effects of high glucose concentration (30 mM) on HUVECs.
Figure S4. Zebrafish/tumor xenograft angiogenesis assay.
Figure S5. BRAF protein expression after miR-492 transfection.
Figure S6. Set up and transfection of VEGF-HUVEC.
Data S1. Supplemental references.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.